Unexpected increase in PSA testing after USPSTF recommendations
January 21st 2022"It is worth remembering that injudicious use of PSA test, and the downstream consequences of overtreatment and complications, can obscure the benefits associated with PSA-based early detection of prostate cancer," writes Badar M. Mian, MD.
Safety, communication, quality: Resolve to improve your practice in 2022
January 17th 2022"Be sure you are prescribing and dispensing the most clinically and cost-effective alternatives for your patients, and check that your information systems (electronic health records) are configured to display formulary information as you prescribe," advises Robert A. Dowling, MD.
Dr. Khera and Dr. Pearlman discuss innovations in testosterone therapy
January 12th 2022In this installment of our 50th Anniversary Innovation Celebration, Amy Pearlman, MD, interviews Mohit Khera, MD, MBA, MPH, on how advancements in testosterone therapy have changed treatment modalities across urology, providing patients with more efficacious, individualized care.
Nivolumab plus ipilimumab linked to treatment-free survival boost in kidney cancer
January 3rd 2022A retrospective analysis of the phase 3 CheckMate-214 trial showed a treatment-free survival advantage with the immunotherapy combination versus the targeted therapy sunitinib in patients with advanced renal cell carcinoma.
Urinary incontinence linked to increased risk of falling in older adults
December 17th 2021“Falls are the leading cause of accidental death in seniors, and many people don’t know that having bladder control problems makes you about twice as likely to fall over,” said William Gibson, MBChB, MRCP, PhD.